APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Postbiotics CDMO Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Postbiotics CDMO Service Market Outlook and Growth Opportunities 2026

Report ID 17421813045 June 2026195 pages

Choose your research edition.

Industry ResearchPostbiotics CDMO Service Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Postbiotics CDMO Service Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Postbiotics CDMO Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Postbiotics CDMO Service Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Postbiotics CDMO Service Market Analysis and Forecast 2026-2032226 pages · $4,950 USD

Market perspective

The global Postbiotics CDMO Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Postbiotics CDMO Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Postbiotics CDMO Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Postbiotics CDMO Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Postbiotics CDMO Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Postbiotics CDMO Service market include ILDONG Bioscience Co., Ltd., Bioprox Healthcare, Exden, JuneYao Group (BioGrowing), dsm-firmenich (Adare Pharma Solutions), Sirio Pharma and Sacco System, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Postbiotics CDMO Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Postbiotics CDMO Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Postbiotics CDMO Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Postbiotics CDMO Service market.

Postbiotics CDMO Service Segment by Company

ILDONG Bioscience Co., Ltd.

Bioprox Healthcare

Exden

JuneYao Group (BioGrowing)

dsm-firmenich (Adare Pharma Solutions)

Sirio Pharma

Sacco System

Postbiotics CDMO Service Segment by Type

Oral Dosage Forms (Capsules And Tablets)

Powders and Granules

Liquid Preparations

Postbiotics CDMO Service Segment by Application

Medicines and Health Products

Food

Pet Food

Cosmetics

Postbiotics CDMO Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Postbiotics CDMO Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Postbiotics CDMO Service key companies, revenue, market share, and recent developments.

3. To split the Postbiotics CDMO Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Postbiotics CDMO Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Postbiotics CDMO Service significant trends, drivers, influence factors in global and regions.

6. To analyze Postbiotics CDMO Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Postbiotics CDMO Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Postbiotics CDMO Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Postbiotics CDMO Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Postbiotics CDMO Service industry.

Chapter 3: Detailed analysis of Postbiotics CDMO Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Postbiotics CDMO Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Postbiotics CDMO Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Postbiotics CDMO Service Industry Trends Table 2. Postbiotics CDMO Service Industry Drivers Table 3. Postbiotics CDMO Service Industry Opportunities and Challenges Table 4. Postbiotics CDMO Service Industry Restraints Table 5. Global Postbiotics CDMO Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Postbiotics CDMO Service Revenue Share by Company (2021-2026) Table 7. Global Postbiotics CDMO Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Postbiotics CDMO Service Key Company Manufacturing Base & Headquarters Table 9. Global Postbiotics CDMO Service Company, Product Type & Application Table 10. Global Postbiotics CDMO Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Postbiotics CDMO Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Oral Dosage Forms (Capsules And Tablets) Table 15. Significant Companies of Powders and Granules Table 16. Significant Companies of Liquid Preparations Table 17. Global Postbiotics CDMO Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Postbiotics CDMO Service Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Postbiotics CDMO Service Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Postbiotics CDMO Service Sales Value Share by Type (2021-2026) Table 21. Global Postbiotics CDMO Service Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Medicines and Health Products Table 23. Significant Companies of Food Table 24. Significant Companies of Pet Food Table 25. Significant Companies of Cosmetics Table 26. Global Postbiotics CDMO Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Postbiotics CDMO Service Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Postbiotics CDMO Service Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Postbiotics CDMO Service Sales Value Share by Application (2021-2026) Table 30. Global Postbiotics CDMO Service Sales Value Share by Application (2027-2032) Table 31. Global Postbiotics CDMO Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Postbiotics CDMO Service Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Postbiotics CDMO Service Sales Value Share by Region (2021-2026) Table 34. Global Postbiotics CDMO Service Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Postbiotics CDMO Service Sales Value Share by Region (2027-2032) Table 36. Global Postbiotics CDMO Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Postbiotics CDMO Service Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Postbiotics CDMO Service Sales Value Market Share by Country (2021-2026) Table 39. Global Postbiotics CDMO Service Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Postbiotics CDMO Service Sales Value Market Share by Country (2027-2032) Table 41. ILDONG Bioscience Co., Ltd. Company Information Table 42. ILDONG Bioscience Co., Ltd. Business Overview Table 43. ILDONG Bioscience Co., Ltd. Postbiotics CDMO Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. ILDONG Bioscience Co., Ltd. Postbiotics CDMO Service Product Portfolio Table 45. ILDONG Bioscience Co., Ltd. Recent Development Table 46. Bioprox Healthcare Company Information Table 47. Bioprox Healthcare Business Overview Table 48. Bioprox Healthcare Postbiotics CDMO Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Bioprox Healthcare Postbiotics CDMO Service Product Portfolio Table 50. Bioprox Healthcare Recent Development Table 51. Exden Company Information Table 52. Exden Business Overview Table 53. Exden Postbiotics CDMO Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Exden Postbiotics CDMO Service Product Portfolio Table 55. Exden Recent Development Table 56. JuneYao Group (BioGrowing) Company Information Table 57. JuneYao Group (BioGrowing) Business Overview Table 58. JuneYao Group (BioGrowing) Postbiotics CDMO Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. JuneYao Group (BioGrowing) Postbiotics CDMO Service Product Portfolio Table 60. JuneYao Group (BioGrowing) Recent Development Table 61. dsm-firmenich (Adare Pharma Solutions) Company Information Table 62. dsm-firmenich (Adare Pharma Solutions) Business Overview Table 63. dsm-firmenich (Adare Pharma Solutions) Postbiotics CDMO Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. dsm-firmenich (Adare Pharma Solutions) Postbiotics CDMO Service Product Portfolio Table 65. dsm-firmenich (Adare Pharma Solutions) Recent Development Table 66. Sirio Pharma Company Information Table 67. Sirio Pharma Business Overview Table 68. Sirio Pharma Postbiotics CDMO Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Sirio Pharma Postbiotics CDMO Service Product Portfolio Table 70. Sirio Pharma Recent Development Table 71. Sacco System Company Information Table 72. Sacco System Business Overview Table 73. Sacco System Postbiotics CDMO Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Sacco System Postbiotics CDMO Service Product Portfolio Table 75. Sacco System Recent Development Table 76. Research Programs/Design for This Report Table 77. Authors List of This Report Table 78. Secondary Sources Table 79. Primary Sources List of Figures Figure 1. Postbiotics CDMO Service Product Image Figure 2. Global Postbiotics CDMO Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Postbiotics CDMO Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Postbiotics CDMO Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Oral Dosage Forms (Capsules And Tablets) Image Figure 8. Powders and Granules Image Figure 9. Liquid Preparations Image Figure 10. Global Postbiotics CDMO Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Postbiotics CDMO Service Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Postbiotics CDMO Service Sales Value Share by Type (2021-2032) Figure 13. Medicines and Health Products Image Figure 14. Food Image Figure 15. Pet Food Image Figure 16. Cosmetics Image Figure 17. Global Postbiotics CDMO Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Postbiotics CDMO Service Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Postbiotics CDMO Service Sales Value Share by Application (2021-2032) Figure 20. Global Postbiotics CDMO Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Postbiotics CDMO Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Postbiotics CDMO Service Sales Value (2021-2032) & (US$ Million) Figure 23. North America Postbiotics CDMO Service Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Postbiotics CDMO Service Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Postbiotics CDMO Service Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Postbiotics CDMO Service Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Postbiotics CDMO Service Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Postbiotics CDMO Service Sales Value (2021-2032) & (US$ Million) Figure 29. South America Postbiotics CDMO Service Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Postbiotics CDMO Service Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Postbiotics CDMO Service Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Postbiotics CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Postbiotics CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Postbiotics CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Postbiotics CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Postbiotics CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Postbiotics CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Postbiotics CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Postbiotics CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Postbiotics CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Postbiotics CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Postbiotics CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Postbiotics CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Postbiotics CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Postbiotics CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Postbiotics CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Postbiotics CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Postbiotics CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Postbiotics CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Postbiotics CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Postbiotics CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Postbiotics CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Postbiotics CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Postbiotics CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Postbiotics CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Postbiotics CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Postbiotics CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Postbiotics CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Postbiotics CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Postbiotics CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Postbiotics CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Postbiotics CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Postbiotics CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Postbiotics CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Postbiotics CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Postbiotics CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Postbiotics CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Postbiotics CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Postbiotics CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Postbiotics CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Postbiotics CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Postbiotics CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Postbiotics CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Postbiotics CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Postbiotics CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Postbiotics CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Postbiotics CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Postbiotics CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Postbiotics CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Postbiotics CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Postbiotics CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Postbiotics CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Postbiotics CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Postbiotics CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Postbiotics CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Postbiotics CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Postbiotics CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Postbiotics CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Postbiotics CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Postbiotics CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Postbiotics CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Postbiotics CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Postbiotics CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Postbiotics CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Postbiotics CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Postbiotics CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Postbiotics CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Postbiotics CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Postbiotics CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Postbiotics CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Postbiotics CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Postbiotics CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Postbiotics CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Postbiotics CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Postbiotics CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Postbiotics CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Postbiotics CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Postbiotics CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Postbiotics CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Postbiotics CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Postbiotics CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Postbiotics CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Postbiotics CDMO Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Postbiotics CDMO Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Postbiotics CDMO Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Oral Dosage Forms (Capsules And Tablets)
  • Powders and Granules
  • Liquid Preparations
Applications
  • Medicines and Health Products
  • Food
  • Pet Food
  • Cosmetics
Companies covered
  • ILDONG Bioscience Co., Ltd.
  • Bioprox Healthcare
  • Exden
  • JuneYao Group (BioGrowing)
  • dsm-firmenich (Adare Pharma Solutions)
  • Sirio Pharma
  • Sacco System

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Postbiotics CDMO Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Postbiotics CDMO Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Postbiotics CDMO Service Market Dynamics
  1. 2.1 Postbiotics CDMO Service Industry Trends
  2. 2.2 Postbiotics CDMO Service Industry Drivers
  3. 2.3 Postbiotics CDMO Service Industry Opportunities and Challenges
  4. 2.4 Postbiotics CDMO Service Industry Restraints
3 Postbiotics CDMO Service Market by Company
  1. 3.1 Global Postbiotics CDMO Service Company Revenue Ranking in 2025
  2. 3.2 Global Postbiotics CDMO Service Revenue by Company (2021-2026)
  3. 3.3 Global Postbiotics CDMO Service Company Ranking (2024-2026)
  4. 3.4 Global Postbiotics CDMO Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Postbiotics CDMO Service Company Product Type and Application
  6. 3.6 Global Postbiotics CDMO Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Postbiotics CDMO Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Postbiotics CDMO Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Postbiotics CDMO Service Market by Type
  1. 4.1 Postbiotics CDMO Service Type Introduction
  2. 4.1.1 Oral Dosage Forms (Capsules And Tablets)
  3. 4.1.2 Powders and Granules
  4. 4.1.3 Liquid Preparations
  5. 4.2 Global Postbiotics CDMO Service Sales Value by Type
  6. 4.2.1 Global Postbiotics CDMO Service Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Postbiotics CDMO Service Sales Value by Type (2021-2032)
  8. 4.2.3 Global Postbiotics CDMO Service Sales Value Share by Type (2021-2032)
5 Postbiotics CDMO Service Market by Application
  1. 5.1 Postbiotics CDMO Service Application Introduction
  2. 5.1.1 Medicines and Health Products
  3. 5.1.2 Food
  4. 5.1.3 Pet Food
  5. 5.1.4 Cosmetics
  6. 5.2 Global Postbiotics CDMO Service Sales Value by Application
  7. 5.2.1 Global Postbiotics CDMO Service Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Postbiotics CDMO Service Sales Value by Application (2021-2032)
  9. 5.2.3 Global Postbiotics CDMO Service Sales Value Share by Application (2021-2032)
6 Postbiotics CDMO Service Regional Value Analysis
  1. 6.1 Global Postbiotics CDMO Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Postbiotics CDMO Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Postbiotics CDMO Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Postbiotics CDMO Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Postbiotics CDMO Service Sales Value (2021-2032)
  7. 6.3.2 North America Postbiotics CDMO Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Postbiotics CDMO Service Sales Value (2021-2032)
  10. 6.4.2 Europe Postbiotics CDMO Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Postbiotics CDMO Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Postbiotics CDMO Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Postbiotics CDMO Service Sales Value (2021-2032)
  16. 6.6.2 South America Postbiotics CDMO Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Postbiotics CDMO Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Postbiotics CDMO Service Sales Value Share by Country, 2025 VS 2032
7 Postbiotics CDMO Service Country-level Value Analysis
  1. 7.1 Global Postbiotics CDMO Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Postbiotics CDMO Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Postbiotics CDMO Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Postbiotics CDMO Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Postbiotics CDMO Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Postbiotics CDMO Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Postbiotics CDMO Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Postbiotics CDMO Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Postbiotics CDMO Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Postbiotics CDMO Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Postbiotics CDMO Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Postbiotics CDMO Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Postbiotics CDMO Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Postbiotics CDMO Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Postbiotics CDMO Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Postbiotics CDMO Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Postbiotics CDMO Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Postbiotics CDMO Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Postbiotics CDMO Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Postbiotics CDMO Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Postbiotics CDMO Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Postbiotics CDMO Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Postbiotics CDMO Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Postbiotics CDMO Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Postbiotics CDMO Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Postbiotics CDMO Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Postbiotics CDMO Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Postbiotics CDMO Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Postbiotics CDMO Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Postbiotics CDMO Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Postbiotics CDMO Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Postbiotics CDMO Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Postbiotics CDMO Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Postbiotics CDMO Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Postbiotics CDMO Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Postbiotics CDMO Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Postbiotics CDMO Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Postbiotics CDMO Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Postbiotics CDMO Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Postbiotics CDMO Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Postbiotics CDMO Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Postbiotics CDMO Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Postbiotics CDMO Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Postbiotics CDMO Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Postbiotics CDMO Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Postbiotics CDMO Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Postbiotics CDMO Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Postbiotics CDMO Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Postbiotics CDMO Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Postbiotics CDMO Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Postbiotics CDMO Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Postbiotics CDMO Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Postbiotics CDMO Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Postbiotics CDMO Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Postbiotics CDMO Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Postbiotics CDMO Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Postbiotics CDMO Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Postbiotics CDMO Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Postbiotics CDMO Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Postbiotics CDMO Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Postbiotics CDMO Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Postbiotics CDMO Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Postbiotics CDMO Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Postbiotics CDMO Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Postbiotics CDMO Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Postbiotics CDMO Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Postbiotics CDMO Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Postbiotics CDMO Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Postbiotics CDMO Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Postbiotics CDMO Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Postbiotics CDMO Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Postbiotics CDMO Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Postbiotics CDMO Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Postbiotics CDMO Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Postbiotics CDMO Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Postbiotics CDMO Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Postbiotics CDMO Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Postbiotics CDMO Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Postbiotics CDMO Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Postbiotics CDMO Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Postbiotics CDMO Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Postbiotics CDMO Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Postbiotics CDMO Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Postbiotics CDMO Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Postbiotics CDMO Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Postbiotics CDMO Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Postbiotics CDMO Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Postbiotics CDMO Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 ILDONG Bioscience Co., Ltd.
  2. 8.1.1 ILDONG Bioscience Co., Ltd. Company Information
  3. 8.1.2 ILDONG Bioscience Co., Ltd. Business Overview
  4. 8.1.3 ILDONG Bioscience Co., Ltd. Postbiotics CDMO Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 ILDONG Bioscience Co., Ltd. Postbiotics CDMO Service Product Portfolio
  6. 8.1.5 ILDONG Bioscience Co., Ltd. Recent Developments
  7. 8.2 Bioprox Healthcare
  8. 8.2.1 Bioprox Healthcare Company Information
  9. 8.2.2 Bioprox Healthcare Business Overview
  10. 8.2.3 Bioprox Healthcare Postbiotics CDMO Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Bioprox Healthcare Postbiotics CDMO Service Product Portfolio
  12. 8.2.5 Bioprox Healthcare Recent Developments
  13. 8.3 Exden
  14. 8.3.1 Exden Company Information
  15. 8.3.2 Exden Business Overview
  16. 8.3.3 Exden Postbiotics CDMO Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Exden Postbiotics CDMO Service Product Portfolio
  18. 8.3.5 Exden Recent Developments
  19. 8.4 JuneYao Group (BioGrowing)
  20. 8.4.1 JuneYao Group (BioGrowing) Company Information
  21. 8.4.2 JuneYao Group (BioGrowing) Business Overview
  22. 8.4.3 JuneYao Group (BioGrowing) Postbiotics CDMO Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 JuneYao Group (BioGrowing) Postbiotics CDMO Service Product Portfolio
  24. 8.4.5 JuneYao Group (BioGrowing) Recent Developments
  25. 8.5 dsm-firmenich (Adare Pharma Solutions)
  26. 8.5.1 dsm-firmenich (Adare Pharma Solutions) Company Information
  27. 8.5.2 dsm-firmenich (Adare Pharma Solutions) Business Overview
  28. 8.5.3 dsm-firmenich (Adare Pharma Solutions) Postbiotics CDMO Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 dsm-firmenich (Adare Pharma Solutions) Postbiotics CDMO Service Product Portfolio
  30. 8.5.5 dsm-firmenich (Adare Pharma Solutions) Recent Developments
  31. 8.6 Sirio Pharma
  32. 8.6.1 Sirio Pharma Company Information
  33. 8.6.2 Sirio Pharma Business Overview
  34. 8.6.3 Sirio Pharma Postbiotics CDMO Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sirio Pharma Postbiotics CDMO Service Product Portfolio
  36. 8.6.5 Sirio Pharma Recent Developments
  37. 8.7 Sacco System
  38. 8.7.1 Sacco System Company Information
  39. 8.7.2 Sacco System Business Overview
  40. 8.7.3 Sacco System Postbiotics CDMO Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Sacco System Postbiotics CDMO Service Product Portfolio
  42. 8.7.5 Sacco System Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst